Skip to main content

Percentage of Patients who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life

CBE ID
0210
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Geriatrics and Palliative Care Spring 2026
1.3 Measure Description

Percentage of patients who died from cancer receiving systemic cancer-directed therapy in the last 14 days of life

        • 1.14 Numerator

          Patients who received systemic cancer-directed therapy in the last 14 days of life. 

           

          Definitions: 

           

          Systemic Cancer-Directed Therapy includes

          • All traditional cytotoxic chemotherapy (such as alkylating agents, antimetabolites, plant alkaloids and terpenoids, topoisomerase inhibitors, and antitumor antibiotics); 
          • Immunotherapy;
          • Biologics (such as Herceptin, Rituxan); and 
          • Targeted agents  

           

          Do not include supportive care therapies (e.g., growth factors, bisphosphonates, RANK ligand inhibitors, nausea medications or fluids if these are not given in association with “systemic cancer-directed therapy”). Hormonal therapies and steroids are not included in this systemic cancer directed therapy definition.

           

        • 1.15 Denominator

          Patients who died from cancer.

        • Exclusions

          None

        • 1.13a Data dictionary not attached
          No
        • Most Recent Endorsement Activity
          Endorsed Geriatric and Palliative Care Spring 2022
          Initial Endorsement
          Last Updated
        • Steward
          American Society of Clinical Oncology
          Steward Organization POC Email
          Steward Organization Copyright

          Copyright © 2012-2016 American Society of Clinical Oncology. All right reserved.

              • Risk adjustment approach
                Off
                Risk adjustment approach
                Off
                Conceptual model for risk adjustment
                Off
                Conceptual model for risk adjustment
                Off